<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81-pharmaceuticals-12-00147">
 <label>81.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Courtin</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Fotso</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Fautrad</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mas</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Alessi</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Riteau</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>143</volume>
  <fpage>252</fpage>
  <lpage>261</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.05.001</pub-id>
  <pub-id pub-id-type="pmid">28483551</pub-id>
 </element-citation>
</ref>
